Patents by Inventor Hua-Chien CHANG

Hua-Chien CHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and biomarker for evaluating cancer metastasis, pharmaceutical composition for inhibiting cancer metastasis, and method for analyzing secretome
    Patent number: 9194005
    Abstract: The invention relates to methods and biomarker for evaluating cancer metastasis, pharmaceutical composition for inhibiting cancer metastasis, and method for analyzing secretome. By combining a hollow fiber cartridge (HFC) culture system with quantitative proteomics technology, cancer metastasis-related secrectomes can be found. Furthermore, this is the first time to use PARK7 as a biomarker for judging the process of non-small cell lung cancer.
    Type: Grant
    Filed: September 17, 2013
    Date of Patent: November 24, 2015
    Assignee: NATIONAL CHENG KUNG UNIVERSITY
    Inventors: Pao-Chi Liao, Ying-Hwa Chang, Shu-Hui Lee, Hua-Chien Chang, Yau-Lin Tseng, Wu-Wei Lai
  • Methods and biomarker for evaluating cancer metastasis, pharmaceutical composition for inhibiting cancer metastasis, and method for analyzing secretome
    Publication number: 20140120528
    Abstract: The invention relates to methods and biomarker for evaluating cancer metastasis, pharmaceutical composition for inhibiting cancer metastasis, and method for analyzing secretome. By combining a hollow fiber cartridge (HFC) culture system with quantitative proteomics technology, cancer metastasis-related secrectomes can be found. Furthermore, this is the first time to use PARK7 as a biomarker for judging the process of non-small cell lung cancer.
    Type: Application
    Filed: September 17, 2013
    Publication date: May 1, 2014
    Applicant: National Cheng Kung University
    Inventors: Pao-Chi LIAO, Ying-Hwa CHANG, Shu-Hui LEE, Hua-Chien CHANG, Yau-Lin TSENG, Wu-Wei LAI